- Home
- QXO vs HOLX Comparison
QXO vs HOLX Comparison
Compare QXO & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QXO
- HOLX
- Stock Information
- Founded
- QXO 1988
- HOLX 1985
- Country
- QXO United States
- HOLX United States
- Employees
- QXO N/A
- HOLX N/A
- Industry
- QXO EDP Services
- HOLX Medical Electronics
- Sector
- QXO Technology
- HOLX Health Care
- Exchange
- QXO Nasdaq
- HOLX Nasdaq
- Market Cap
- QXO 12.8B
- HOLX 15.0B
- IPO Year
- QXO N/A
- HOLX 1990
- Fundamental
- Price
- QXO $19.77
- HOLX $67.78
- Analyst Decision
- QXO Strong Buy
- HOLX Buy
- Analyst Count
- QXO 12
- HOLX 14
- Target Price
- QXO $33.64
- HOLX $78.92
- AVG Volume (30 Days)
- QXO 8.8M
- HOLX 2.3M
- Earning Date
- QXO 11-12-2025
- HOLX 11-03-2025
- Dividend Yield
- QXO N/A
- HOLX N/A
- EPS Growth
- QXO N/A
- HOLX N/A
- EPS
- QXO N/A
- HOLX 2.41
- Revenue
- QXO $1,947,673,000.00
- HOLX $4,038,900,000.00
- Revenue This Year
- QXO $13,023.98
- HOLX $3.37
- Revenue Next Year
- QXO $56.11
- HOLX $4.51
- P/E Ratio
- QXO N/A
- HOLX $28.05
- Revenue Growth
- QXO 3309.07
- HOLX 1.29
- 52 Week Low
- QXO $11.85
- HOLX $51.90
- 52 Week High
- QXO $24.69
- HOLX $84.39
- Technical
- Relative Strength Index (RSI)
- QXO 44.66
- HOLX 52.07
- Support Level
- QXO $18.27
- HOLX $66.94
- Resistance Level
- QXO $21.14
- HOLX $68.45
- Average True Range (ATR)
- QXO 0.72
- HOLX 1.66
- MACD
- QXO 0.01
- HOLX 0.06
- Stochastic Oscillator
- QXO 41.17
- HOLX 67.38
About QXO QXO Inc. Common Stock
QXO Inc is a building products distribution company engaged in the distribution of roofing, waterproofing and complementary building products in North America. It offers a full suite of business applications, including ERP, warehouse management, accounting, CRM, and business intelligence solutions.
About HOLX Hologic Inc.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.